GlassScriptPhysician profile
Rahul Sharma
NPI 1235192220
$59,814.98
in general payments reported to CMS, 2019-2025
21 companies · $242 in 2025
The $242 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $260 · 2021: $1,104 · 2022: $20K · 2023: $24K · 2024: $331 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $23K · Food and Beverage: $1,279 · Travel and Lodging: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $23,100.00 |
| Food and Beverage | $1,278.83 |
| Travel and Lodging | $234.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $30,012.22 | 2019-2023 | |
| Shockwave Medical, INC | $23,428.23 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $3,001.23 | 2019-2025 | Mitraclip, Amplatzer Amulet |
| Boston Scientific Corporation | $2,026.81 | 2019-2022 | |
| Organon LLC | $282.35 | 2021-2025 | Nexplanon |
| Coopersurgical, INC. | $142.75 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Medtronic Vascular, INC. | $138.50 | 2019 | |
| Merck Sharp & Dohme LLC | $130.22 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $126.59 | 2019-2023 | |
| Hologic Sales and Service, LLC | $105.00 | 2019-2025 | Myosure Tissue Removal Device, Aptima |
| Abbvie INC. | $100.94 | 2019-2021 | |
| Sage Therapeutics, LLC | $94.00 | 2019-2025 | Zurzuvae |
| Shield Therapeutics INC | $61.64 | 2024-2025 | |
| Therapeuticsmd, INC. | $33.79 | 2020-2021 | |
| Pfizer INC. | $23.87 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $21.59 | 2021 | |
| Agile Therapeutics, INC. | $19.41 | 2022 | |
| Mayne Pharma Commercial LLC | $18.70 | 2024 | |
| Sumitomo Pharma America, INC. | $17.33 | 2023 | Myfembree |
| Currax Pharmaceuticals LLC | $15.41 | 2021 | |
| Merz North America, INC. | $14.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rahul Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.